National and Kapodistrian University of Athens
Πειραματική απομόνωση και μεταμόσχευση μεσεγχυματικών κυττάρων (mesenchymal stem cells) σε πειραματικό πρότυπο 50 - 60% ηπατεκτομής σε αρουραίους: ειδική βιοχημική μελέτη
Abstract
dc:descriptionLoss of liver mass may be induced by several factors, such as hepatitis virus infection, drug and hepatotoxic chemicals administration, metabolic diseases, trauma, as well as surgical procedures in the liver, and can lead to liver failure (LF). LF is one of the leading causes of morbidity and mortality worldwide. The only effective treatment so far for acute and chronic LF is liver transplantation, with its associated limitations, including the shortage of liver donors and the need for continuous immunosuppression.Mesenchymal stem cells (MSCs) present a promising therapeutic method to alleviate end stage liver disease (ESLD) and LF. Although a number of reports have demonstrated the effectiveness of BM-MSCs in hepatic regeneration, certain characteristics of adipose tissue stem cells (ADSCs) render them as an attractive option for liver repopulation. ADSCs are in abundance and may be harvested with the use of minimally invasive procedures. Moreover, they show a stronger commitment to hepatic lineage, as well as higher rates of proliferation, compared with BM-MSCs.The findings of the present study demonstrated that a pre-transplantation differentiation of ADSCs towards the hepatic lineage is not a prerequisite for a successful outcome, since the transplanted undifferentiated ADSCs were already successfully engrafted into the liver parenchyma from the 4th postoperative day (POD), and were still localized in the liver till the 15th POD, which was the end of the follow-up period.The successful engraftment of the transplanted ADSCs into the liver parenchyma was followed by a definitive enhancement of the liver regeneration rate in the transplanted animals till the 7th POD, accompanied by an amelioration of the histopathologic damage on the 7th and 15th POD, as well as by a promotion of the synthetic ability of the liver, and an up-regulation of the expression of liver regeneration and liver-specific genes, in the transplanted animals.Several studies have focused on the optimal route of transplantation of MSCs, and the optimal number of transplanted MSCs. The present study demonstrated that, although the intrahepatic (IH) administration of ADSCs rendered the best results, in promoting the liver regeneration process, compared with the respective control group on the 4th and 7th POD of sacrifice, no other specific significant differences were identified among the transplanted animals, as for the number and route of administration of ADSCs, a finding also supported by the aforementioned results, as well as several other studies.There is limited time in treating and saving a patient, suffering from acute liver failure (ALF). In this context, the results of the present study are of particular value, when applied to a clinical setting. The cornerstone of our study is the successful transplantation and localization of ADSCs into the liver parenchyma, without a previous in vitro differentiation towards the hepatic lineage, which needs at least two weeks to complete. This results in a faster and definitive enhancement of the liver regeneration process, as well as in an up-regulation of the synthetic ability of the liver, when compared with the non–transplanted groups of animals, without at the same time sacrificing any time in the differentiation process, which may be proven life – salutary, in the clinical context.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Apostolou, Konstantinos
- Αποστόλου, Κωνσταντίνος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42833